RT @david_lagares: Ephrin-B2 is an emerging therapeutic target for lung, liver, cardiac and skin fibrosis. Read our latest Review with the…
RT @david_lagares: Ephrin-B2 is an emerging therapeutic target for lung, liver, cardiac and skin fibrosis. Read our latest Review with the…
RT @Amandality: Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis. - PubMed - NCBI https://t.co/kE9Bedq4xu Recent article fr…
RT @PulmaoSA: The #Ephrin involvement in #lung fibrosis #IPF #CPFE / #SSc & other organs by @david_lagares, et al: A new #antifibrotic #ta…
RT @david_lagares: Ephrin-B2 is an emerging therapeutic target for lung, liver, cardiac and skin fibrosis. Read our latest Review with the…
RT @david_lagares: Ephrin-B2 is an emerging therapeutic target for lung, liver, cardiac and skin fibrosis. Read our latest Review with the…
The #Ephrin involvement in #lung fibrosis #IPF #CPFE / #SSc & other organs by @david_lagares, et al: A new #antifibrotic #target 🎯 on the block: https://t.co/b5ud5TW5jo https://t.co/Zxgvv6xA1y
Ephrin-B2 is an emerging therapeutic target for lung, liver, cardiac and skin fibrosis. Read our latest Review with the Kapoor Lab: "Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis". Open Access Link. https://t.co/rB1sfMFtkS https://t.co/
Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis. - PubMed - NCBI https://t.co/kE9Bedq4xu Recent article from the Kapoor Lab